|
Market Closed -
Nasdaq
16:00:00 2026-10-22 EDT
|
5-day change | 1st Jan Change | ||
| 23.50 USD | +2.55% |
|
+1.38% | -49.24% |
| 10-19 | Collegium Pharmaceutical Settles Nucynta Patent Litigation for $17 Million | MT |
| 10-09 | Collegium Pharmaceutical Outlook Supported by ADHD Trends, Low Generic Drug Risk, Oppenheimer Says | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +2.55% | +1.38% | +3.16% | -32.32% | -49.24% | -34.19% | +9.46% | +11.59% | +28.42% | 746M | |
| +2.83% | +4.40% | +11.67% | +12.35% | +21.59% | +60.84% | +123.50% | +436.08% | +1,569.89% | 1,165B | |
| +3.81% | +5.66% | -0.59% | +4.69% | +29.31% | +38.70% | +74.91% | +63.46% | +135.90% | 645B | |
| +0.14% | +0.63% | +7.53% | +12.59% | +24.82% | +24.71% | +95.03% | +161.31% | +367.68% | 504B | |
| -0.69% | +2.95% | +7.49% | +11.70% | +18.95% | +43.74% | +64.34% | +9.28% | +69.22% | 380B | |
| -1.76% | +1.41% | -2.43% | +15.51% | +39.88% | +68.06% | +43.41% | +81.44% | +140.59% | 363B | |
| -1.21% | +2.60% | +8.79% | +0.22% | +16.73% | +22.41% | +51.41% | +66.11% | +71.50% | 297B | |
| -1.47% | +3.20% | +3.33% | +1.23% | -6.86% | +2.78% | +27.17% | +43.64% | +164.77% | 269B | |
| +2.04% | +3.05% | +9.03% | +22.19% | +36.65% | +51.12% | +60.42% | +113.76% | +182.18% | 237B | |
| +2.36% | -0.11% | +2.96% | +20.60% | +28.07% | +29.42% | +102.04% | +133.77% | +111.59% | 195B | |
| -0.47% | +1.66% | +4.62% | -17.61% | -18.86% | -23.06% | -61.32% | -22.53% | +87.10% | 175B | |
| +1.91% | +3.33% | +8.92% | +22.56% | +22.17% | +23.06% | -0.75% | -29.52% | -5.47% | 173B | |
| +2.03% | +5.19% | +3.92% | +13.25% | +18.05% | +25.50% | +47.89% | +191.61% | +562.67% | 133B | |
| +3.08% | +4.01% | +1.20% | +3.69% | +16.80% | +41.92% | +11.58% | +9.38% | +25.95% | 129B | |
| -0.31% | +1.37% | +13.59% | +24.36% | +23.41% | +27.24% | +123.57% | +384.16% | +528.67% | 118B | |
| -1.20% | +2.04% | +0.77% | -0.26% | +4.17% | +15.43% | +29.96% | +6.72% | -7.35% | 103B | |
| -0.91% | +3.22% | +1.57% | -2.75% | -10.23% | -14.26% | -24.46% | -13.18% | +7.31% | 101B | |
| -17.57% | -14.32% | +10.99% | +248.94% | +587.11% | +654.67% | +152.03% | -37.95% | - | 80.9B | |
| +1.67% | +2.86% | +1.89% | +25.79% | +6.12% | +40.08% | +1.31% | +43.11% | +125.32% | 81.79B | |
| -1.64% | +0.49% | +9.06% | +4.13% | +18.27% | +25.81% | +0.10% | -28.64% | +47.33% | 71.29B | |
| Average | +0.60% | +1.64% | +5.37% | +19.54% | +41.35% | +56.20% | +46.58% | +81.18% | +221.75% | 261.09B | |
| Weighted average by Cap. | +1.21% | +2.35% | +6.08% | +13.72% | +29.12% | +46.93% | +69.26% | +154.82% | +481.99% |
- Stock Market
- Stocks
- COLL Stock
- Sector Collegium Pharmaceutical, Inc.
Select your edition
All financial news and data tailored to specific country editions
